Dusan Stefoski to Interleukin-2 Receptor alpha Subunit
This is a "connection" page, showing publications Dusan Stefoski has written about Interleukin-2 Receptor alpha Subunit.
Connection Strength
0.139
-
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study. BMC Neurol. 2016 Jul 26; 16:117.
Score: 0.139
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.